Riluzole is a glutamate-modulating agent with neuroprotective properties approved for use in amyotrophic lateral sclerosis. The efficacy and safety of riluzole vs placebo as an adjunct to ...
On Thursday, Aldeyra Therapeutics (NASDAQ:ALDX) received reaffirmation from Jones Trading on its Buy rating and $7.00 price target. The firm's position comes after the company disclosed updates from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback